StockData
Citius Oncology, Inc. logo

Citius Oncology, Inc. (CTOR) stock

CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.55+0.01 (+2.36%)

Close on Nov 17, 2026Market cap $50.92MP/E –Yield –

Citius Oncology total assets

Total assets on the balance sheet at the end of each period.

Citius Oncology's total assets was $112.09M at Jun 30, 2026. For fiscal 2025 it was $100.94M, up 48.0% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Sep 30, 2025$100.94M+48.0%
FY2022Dec 31, 2022$68.19M+53838.7%
FY2021Dec 31, 2021$126.42K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$112.09M+22.2%
Q2 FY2026CQ1 2026Mar 31, 2026$100.70M+10.1%
Q1 FY2026CQ4 2025Dec 31, 2025$109.97M+21.5%
Q4 FY2025CQ3 2025Sep 30, 2025$100.94M+48.0%
Q3 FY2025CQ2 2025Jun 30, 2025$91.71M+35619.9%
Q2 FY2025CQ1 2025Mar 31, 2025$91.44M+72228.7%
Q1 FY2025CQ4 2024Dec 31, 2024$90.48M–
Q4 FY2022CQ4 2022Dec 31, 2022$68.19M–
Q3 FY2022CQ3 2022Sep 30, 2022$256.75K–
Q4 FY2021CQ4 2021Dec 31, 2021$126.42K–

More Citius Oncology figures

See a number that looks wrong?